Skip to content

Comparison of Obturator Nerve Blockade and Neuromuscular Blockade

Comparison of Obturator Nerve Blockade and Neuromuscular Blockade for the Prevention of Adductor Spasm in Patients Undergoing Transurethral Resection of Bladder Tumors.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03063255
Enrollment
60
Registered
2017-02-24
Start date
2017-04-25
Completion date
2019-09-19
Last updated
2021-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of Bladder

Brief summary

Patients diagnosed with posterolateral bladder tumors will be invited to participate in the study. Subjects will be randomized to receive an ultrasound-guided obturator block or a neuromuscular blocking agent after the induction of general anesthesia in an attempt to block the obturator reflex during surgery.

Detailed description

The purpose of this research is to compare the incidence of adductor spasm in patients undergoing general anesthesia with neuromuscular blocking agents versus obturator block. Transurethral resection of bladder tumor(s) (TURBT) is a commonly performed procedure to diagnose and treat bladder cancer. The obturator nerve is located lateral to the bladder wall in the pelvis prior to innervating the adductor muscles of the thigh. Depending on the location of the tumor(s), electrocautery or surgical stimulation may result in stimulation of the obturator nerve, resulting in adduction of the leg, which is called the adductor reflex or spasm. This may occur violently and unexpectedly, and result in bladder perforation, bleeding, or cancer dissemination.

Interventions

Subjects allocated to the obturator block group will be monitored for the incidence of block and procedure-related adverse events. In addition to clinical observation, a Nerve Integrity Monitor (Medtronic) will be used to detect adductor spasm using continuous electromyography. Electrodes will be placed on the thigh to objectively detect and record instances of adductor spasm. One hour after arrival to post-anaesthesia care unit (PACU) or when discharge criteria are met (whichever comes first), repeat dynamometer measurements and TUG tests will be performed. Patients will be called 24-48 hours post procedure to inquire about falls or evidence of nerve injury, as well as patient satisfaction.

DRUGNeuromuscular block

Subjects allocated to the neuromuscular block group will be monitored for the incidence of block and procedure-related adverse events. In addition to clinical observation, a Nerve Integrity Monitor (Medtronic) will be used to detect adductor spasm using continuous electromyography. Electrodes will be placed on the thigh to objectively detect and record instances of adductor spasm. One hour after arrival to PACU or when discharge criteria are met (whichever comes first), repeat dynamometer measurements and TUG tests will be performed. Patients will be called 24-48 hours post procedure to inquire about falls or evidence of nerve injury, as well as patient satisfaction.

Sponsors

US Department of Veterans Affairs
CollaboratorFED
University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Sixty subjects with be randomized to the obturator block or neuromuscular block arm upon enrollment, using randomized permutated blocks of six.

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients ≥ 18 years of age * Planned TURBT for unilateral or bilateral posterolateral bladder tumors * Ability to understand and provide informed consent

Exclusion criteria

* Patient refusal or inability to provide informed consent * True allergy, not sensitivity, to local anesthetics * True allergy, not sensitivity, Propofol * True allergy, not sensitivity, general anesthetic agents * Pregnancy * Severe hepatic impairment * Evidence of infection at or near the proposed needle insertion site * Any sensorimotor deficit of the lower extremity, whether acute or chronic * Inability to walk without assistance * Lower extremity joint replacement surgery in the preceding six months

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients With Incidence of Intraoperative Adductor SpasmintraoperativeNerve Integrity Monitor will be used to detect adductor spasm and below are listed the numbers or patients with increased incidence of adductor spasm.

Secondary

MeasureTime frameDescription
Number Patients With Increased Risk of FallingChanges from baseline (pre-op) to 72 hours post-operativeBased on TUG time measurements of patients below are the numbers of patients with an increased risk of falling.
Number of Patients With Incidence of Leg WeaknessChanges from baseline (pre-op) to 72 hours post-operativeTest the strength of subject's lower extremity muscles on the timed up and go (TUG) test and determine how many patients had increased leg weakness.

Countries

United States

Participant flow

Recruitment details

The first subject enrolled was on 04/25/2017 and the last subject enrolled was on 6/11/2019. All subjects were enrolled at the Malcom Randall VAMC.

Participants by arm

ArmCount
Obturator Block
Comparing the incidence of adductor spasm in patients undergoing general anesthesia with obturator block. Obturator block: Subjects allocated to the obturator block group will be monitored for the incidence of block and procedure-related adverse events. In addition to clinical observation, a Nerve Integrity Monitor (Medtronic) will be used to detect adductor spasm using continuous electromyography. Electrodes will be placed on the thigh to objectively detect and record instances of adductor spasm. One hour after arrival to post-anaesthesia care unit (PACU) or when discharge criteria are met (whichever comes first), repeat dynamometer measurements and TUG tests will be performed. Patients will be called 24-48 hours post procedure to inquire about falls or evidence of nerve injury, as well as patient satisfaction.
30
Neuromuscular Block
Comparing the incidence of adductor spasm in patients undergoing general anesthesia with neuromuscular blocking agents. Neuromuscular block: Subjects allocated to the neuromuscular block group will be monitored for the incidence of block and procedure-related adverse events. In addition to clinical observation, a Nerve Integrity Monitor (Medtronic) will be used to detect adductor spasm using continuous electromyography. Electrodes will be placed on the thigh to objectively detect and record instances of adductor spasm. One hour after arrival to PACU or when discharge criteria are met (whichever comes first), repeat dynamometer measurements and TUG tests will be performed. Patients will be called 24-48 hours post procedure to inquire about falls or evidence of nerve injury, as well as patient satisfaction.
30
Total60

Baseline characteristics

CharacteristicNeuromuscular BlockTotalObturator Block
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
28 Participants52 Participants24 Participants
Age, Categorical
Between 18 and 65 years
2 Participants8 Participants6 Participants
Age, Continuous72.2 years
STANDARD_DEVIATION 6.3
71.3 years
STANDARD_DEVIATION 6.8
70.2 years
STANDARD_DEVIATION 7.3
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
30 participants60 participants30 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
30 Participants60 Participants30 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 290 / 30
other
Total, other adverse events
0 / 290 / 30
serious
Total, serious adverse events
0 / 290 / 30

Outcome results

Primary

Number of Patients With Incidence of Intraoperative Adductor Spasm

Nerve Integrity Monitor will be used to detect adductor spasm and below are listed the numbers or patients with increased incidence of adductor spasm.

Time frame: intraoperative

Population: Data entry error correction, one patient withdrawn and only demographic information collected

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Obturator BlockNumber of Patients With Incidence of Intraoperative Adductor Spasm1 Participants
Neuromuscular BlockNumber of Patients With Incidence of Intraoperative Adductor Spasm5 Participants
Secondary

Number of Patients With Incidence of Leg Weakness

Test the strength of subject's lower extremity muscles on the timed up and go (TUG) test and determine how many patients had increased leg weakness.

Time frame: Changes from baseline (pre-op) to 72 hours post-operative

Population: Data entry error correction, one patient withdrawn and only demographic information collected

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Obturator BlockNumber of Patients With Incidence of Leg Weakness27 Participants
Neuromuscular BlockNumber of Patients With Incidence of Leg Weakness22 Participants
Secondary

Number Patients With Increased Risk of Falling

Based on TUG time measurements of patients below are the numbers of patients with an increased risk of falling.

Time frame: Changes from baseline (pre-op) to 72 hours post-operative

Population: Data entry error correction, one patient withdrawn and only demographic information collected

ArmMeasureValue (NUMBER)
Obturator BlockNumber Patients With Increased Risk of Falling28 participants
Neuromuscular BlockNumber Patients With Increased Risk of Falling29 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026